OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB
Giuseppe Tringali, Catello Vollono, Paolo Calabresi, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Giuseppe Tringali, Catello Vollono, Paolo Calabresi, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Showing 10 citing articles:
Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
Fabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 57
Fabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 57
Salivary CGRP and Erenumab Treatment Response: Towards Precision Medicine in Migraine
Alicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Annals of Neurology (2022) Vol. 92, Iss. 5, pp. 846-859
Closed Access | Times Cited: 43
Alicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Annals of Neurology (2022) Vol. 92, Iss. 5, pp. 846-859
Closed Access | Times Cited: 43
Mode and site of action of therapies targeting CGRP signaling
Alejandro Labastida‐Ramírez, Edoardo Caronna, Cédric Gollion, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 33
Alejandro Labastida‐Ramírez, Edoardo Caronna, Cédric Gollion, et al.
The Journal of Headache and Pain (2023) Vol. 24, Iss. 1
Open Access | Times Cited: 33
Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data
Simona Guerzoni, Carlo Baraldi, Umberto Pensato, et al.
Neurological Sciences (2022) Vol. 43, Iss. 6, pp. 3823-3830
Closed Access | Times Cited: 16
Simona Guerzoni, Carlo Baraldi, Umberto Pensato, et al.
Neurological Sciences (2022) Vol. 43, Iss. 6, pp. 3823-3830
Closed Access | Times Cited: 16
Cardiovascular Disease and Migraine: Are the New Treatments Safe?
Jennifer Robblee, Lauren K. Harvey
Current Pain and Headache Reports (2022) Vol. 26, Iss. 8, pp. 647-655
Closed Access | Times Cited: 15
Jennifer Robblee, Lauren K. Harvey
Current Pain and Headache Reports (2022) Vol. 26, Iss. 8, pp. 647-655
Closed Access | Times Cited: 15
Serum CGRP in migraine patients using erenumab as preventive treatment
Simone de Vries Lentsch, Ingrid M. Garrelds, A.H. Jan Danser, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Simone de Vries Lentsch, Ingrid M. Garrelds, A.H. Jan Danser, et al.
The Journal of Headache and Pain (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Change of CGRP Plasma Concentrations in Migraine after Discontinuation of CGRP-(Receptor) Monoclonal Antibodies
Bianca Raffaelli, Maria Terhart, Mira Pauline Fitzek, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 293-293
Open Access | Times Cited: 5
Bianca Raffaelli, Maria Terhart, Mira Pauline Fitzek, et al.
Pharmaceutics (2023) Vol. 15, Iss. 1, pp. 293-293
Open Access | Times Cited: 5
Developments in targeting calcitonin gene-related peptide
Sawsan Alabbad, Nathalia Figueredo, Hsiangkuo Yuan, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 477-485
Closed Access
Sawsan Alabbad, Nathalia Figueredo, Hsiangkuo Yuan, et al.
Expert Review of Neurotherapeutics (2024) Vol. 24, Iss. 5, pp. 477-485
Closed Access
(CGRP) Monocloncal antibodies
Claudia Altamura, Luigi Francesco Iannone, Luisa Fofi, et al.
Elsevier eBooks (2024), pp. 363-394
Closed Access
Claudia Altamura, Luigi Francesco Iannone, Luisa Fofi, et al.
Elsevier eBooks (2024), pp. 363-394
Closed Access
Discontinuing Monoclonal Antibodies Targeting CGRP Pathway After One-Year Treatment: An Observational Longitudinal Cohort Study
Fabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
Research Square (Research Square) (2021)
Open Access
Fabrizio Vernieri, Nicoletta Brunelli, Roberta Messina, et al.
Research Square (Research Square) (2021)
Open Access
